/Investor DB

BioVentures

Venture capital

Belmont · 3 people tracked

Not to be confused with BioVentures LP (Venture capital · Bronxville, US)

Find your way into BioVentures

Sign up to see every warm intro you have to BioVentures

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the BioVentures team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Fund manager profile

BioVentures is a venture fund manager based in Belmont. SEC filings show 3 venture funds on record, most recently 7G BioVentures I, L.P. ($100M offering) filed November 2023.

Source: SEC EDGAR Form D filings. Firm website data not yet available.

HQ
Belmont, US
Founded
2018
Tracked investments
4
IPOs
1

Team · 3 people

from public directories
Wenkai Xiang· General Partner

What they invest in

from 4 of 4 portfolio companies

Biotech ×3Healthtech ×3Medical Devices ×3AI & Machine Learning ×1Deep Tech ×1Digital Health ×1Hardware ×1

HQs:United States×4

Investments · 4 tracked

founders shown can be your intro path

By year:2020 · 12019 · 12015 · 12010 · 14 dated

Profusaprofusa.comin𝕏NASDAQ: PFSAJun 2015SEC filingmedium confidence

Profusa develops injectable hydrogel biosensors and AI-driven health platforms that enable real-time measurement of body chemistry from within tissue.

AI & Machine LearningDigital HealthHealthtechMedical DevicesSan Francisco, US

Bill Fawcett(Co-founder)Natalie Wisniewski(Executive Officer, Director)inBill McMillan(Co-Founder, CSO & Head of Research)Ben Healy(CEO)Ben Hwang(Chairman & CEO)in

Board seatQianye Karen Liu· per SEC Form D · $17M raise · filed Jul 2015

Co-investors3E Bioventures CapitalAsset Management CompanyAtinum Investment Co. Ltd.Sand Hill Angels

Avirmaxavirmax.comin𝕏Nov 2019SEC filinghigh confidence

Avirmax is a preclinical-stage biopharmaceutical company developing AAV-based genetic medicines to treat chronic and degenerative ocular diseases.

BiotechDeep TechMedical DevicesHayward, US

Haifeng Chen(Director and Treasurer of the Issuer)inShengjiang Liu(Executive Officer, Director)

BoardNancy Chang(Director of the Issuer)

Board seatQianye Karen LiuYu Fang· per SEC Form D · $10M raise · filed Nov 2019

Co-investors3E Bioventures Capital

Purinomia Biotechpurinomia.cominMay 2020SEC filingmedium confidence

Purinomia is a clinical-stage biotechnology company developing therapeutics for cancer and inflammatory diseases.

BiotechHealthtechWeston, US

CEO & Scientific Founder(CEO & Scientific Founder)Yan Wu(CEO & Scientific Founder)Haitao Zhao(Scientific Founder)Simon Robson(Scientific Founder)in

Board seatQianye Karen Liu· per SEC Form D · $3.8M raise · filed May 2020

Hydrocisionhydrocision.comin𝕏Sep 2010

HydroCision develops minimally invasive surgical instruments using proprietary FluidJet technology to selectively remove soft tissue in a precise manner.

BiotechHardwareHealthtechMedical DevicesNorth Billerica, US

PAUL KOWALSKI(Executive Officer)inRICHARD A. LYTLE, III(Executive Officer, Director)THOMAS D. ABERT(Executive Officer)inPATRICIA VANBLARCOM(Executive Officer)Rick Lytle(President & Chief Executive Officer)in

BoardLONG ZHAN(Director)

Co-investorsNewbury VenturesOxford Bioscience Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 1

1 IPOs

ProfusaNASDAQ: PFSA

Portfolio news

latest coverage across their companies

Frequently asked questions

Where is BioVentures located?
BioVentures is headquartered in Belmont, US.